Galderma Group N (GALD SW) stock market data APIs
CHF126.8269
0.77(0.6%)
as of July 10, 2025
Try our APIs with
free plan!
Galderma Group N Financial Data Overview
Price chart is built with
Anychart
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Prev. Close
126.8269
Open
127.6009
High
128.7647
Low
126.6151
52 wk Range
64.6421-128.6
Market Cap
30 317 M
P/E Ratio
168.0263
Shares Outstanding
237 M
Revenue
4 440 M
EPS
0.55
Dividends (Yield)
0.0013
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Galderma Group N data using free add-ons & libraries
Get Galderma Group N Fundamental Data
Galderma Group N Fundamental data includes:
- Net Revenue: 4 440 M
- EBITDA: 891 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-07-25
- EPS/Forecast: 1.12
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Galderma Group N News
New
3 European Stock Picks Estimated To Be Trading At Up To 46.8% Discount
As the pan-European STOXX Europe 600 Index remains relatively flat and major stock indexes exhibit mixed returns, investors are keenly observing economic indicators such as inflation rates and labor m...
European Stocks That May Be Trading Below Estimated Value In July 2025
As the European markets show signs of recovery, with the STOXX Europe 600 Index climbing 1.32% and Germany's DAX up by nearly 3%, investor optimism is bolstered by easing geopolitical tensions and pot...
Galderma Announces Departure of Its Chief Financial Officer
Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland, July 01, 2025--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittr...
UBS downgrades Galderma stock rating to neutral citing limited upside
Investing.com - UBS downgraded Galderma Group AG (SWX:GALD) from Buy to Neutral on Monday, while lowering its price target to CHF120.00 from CHF128.00. The downgrade follows recent strong share price...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
